Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS) Insider Trading
Directors, officers and holders of more than 10% of EBS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 144 transactions on file: 0 with code P, 11 with code S and 39 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 7, 2026 | DeGolyer Donald W | Director | S Sale | 17,800 | $7.09 | $126,202 |
| Oct 1, 2026 | Williams Paul Anthony | SVP, Products Business | S Sale | 3,000 | $6.53 | $19,590 |
| Jul 1, 2026 | Williams Paul Anthony | SVP, Products Business | S Sale | 3,000 | $8.40 | $25,200 |
| Jun 8, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F Tax Payment | 2,018 | $8.00 | $16,144 |
| Jun 8, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F Tax Payment | 3,964 | $8.00 | $31,712 |
| Jun 8, 2026 | Hartzel William | SVP, Bioservices | F Tax Payment | 1,741 | $8.00 | $13,928 |
| Jun 8, 2026 | Williams Paul Anthony | SVP, Products Business | F Tax Payment | 694 | $8.00 | $5,552 |
| May 1, 2026 | Dayal Sujata Tyagi | Director | S Sale | 12,781 | $8.36 | $106,849 |
| May 1, 2026 | DeGolyer Donald W | Director | S Sale | 14,527 | $8.36 | $121,446 |
| May 1, 2026 | Zoon Kathryn C | Director | S Sale | 1,057 | $8.97 | $9,481 |
| May 1, 2026 | DeGolyer Donald W | Director | S Sale | 954 | $8.96 | $8,548 |
| May 1, 2026 | Zoon Kathryn C | Director | S Sale | 16,145 | $8.36 | $134,972 |
| May 1, 2026 | Dayal Sujata Tyagi | Director | S Sale | 980 | $8.94 | $8,761 |
| Apr 30, 2026 | Harsanyi Zsolt | Chairman | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | Zoon Kathryn C | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | DeGolyer Donald W | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | DeGolyer Donald W | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | Katkin Keith | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | Richard Ronald | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | Harsanyi Zsolt | Chairman | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | Dayal Sujata Tyagi | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | White Marvin L | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | Katkin Keith | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | Richard Ronald | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | FOWLER JOHN D JR | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | FOWLER JOHN D JR | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | Fowler Neal Franklin | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | Katkin Keith | Director | S Sale | 15,481 | $8.28 | $128,183 |
| Apr 30, 2026 | Dayal Sujata Tyagi | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | Fowler Neal Franklin | Director | A Award | 11,296 | Not measured | Not measured |
| Apr 30, 2026 | White Marvin L | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 30, 2026 | Zoon Kathryn C | Director | A Award | 25,344 | Not measured | Not measured |
| Apr 29, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | A Award | 100,111 | Not measured | Not measured |
| Apr 29, 2026 | Williams Paul Anthony | SVP, Products Business | A Award | 100,111 | Not measured | Not measured |
| Apr 29, 2026 | Lowry Simon C | SVP, R&D, CMO | A Award | 100,111 | Not measured | Not measured |
| Apr 29, 2026 | Hartzel William | SVP, Bioservices | A Award | 100,111 | Not measured | Not measured |
| Apr 29, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | A Award | 162,680 | Not measured | Not measured |
| Apr 29, 2026 | Perl Jessica | SVP, General Counsel, Corp Sec | A Award | 104,282 | Not measured | Not measured |
| Apr 29, 2026 | PAPA JOSEPH C | President and CEO | A Award | 187,708 | Not measured | Not measured |
| Apr 1, 2026 | Williams Paul Anthony | SVP, Products Business | S Sale | 4,000 | $8.44 | $33,760 |
| Mar 5, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F Tax Payment | 8,199 | $8.44 | $69,200 |
| Mar 5, 2026 | PAPA JOSEPH C | President and CEO | F Tax Payment | 37,055 | $8.44 | $312,744 |
| Mar 5, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F Tax Payment | 23,650 | $8.44 | $199,606 |
| Mar 5, 2026 | Williams Paul Anthony | SVP, Products Business | F Tax Payment | 9,397 | $8.44 | $79,311 |
| Mar 5, 2026 | Lowry Simon C | SVP, R&D, CMO | F Tax Payment | 10,636 | $8.44 | $89,768 |
| Mar 5, 2026 | Hartzel William | SVP, Bioservices | F Tax Payment | 9,493 | $8.44 | $80,121 |
| Mar 5, 2026 | Perl Jessica | SVP, General Counsel, Corp Sec | F Tax Payment | 6,465 | $8.44 | $54,565 |
| Mar 3, 2026 | Hartzel William | SVP, Bioservices | A Award | 44,834 | Not measured | Not measured |
| Mar 3, 2026 | Perl Jessica | SVP, General Counsel, Corp Sec | A Award | 46,702 | Not measured | Not measured |
| Mar 3, 2026 | Lowry Simon C | SVP, R&D, CMO | A Award | 44,834 | Not measured | Not measured |
The full Form 4 history is on the EBS company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.